Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands

Centronuclear myopathy (CNM) is a genetically heterogeneous congenital myopathy characterized by muscle weakness, atrophy, and variable degrees of cardiorespiratory involvement. The clinical severity is largely explained by genotype (DNM2, MTM1, RYR1, BIN1, TTN, and other rarer genetic backgrounds), specific mutation(s), and age of the patient. The histopathological hallmark of CNM is the presence of internal centralized nuclei on muscle biopsy. Information on the phenotypical spectrum, subtype prevalence, and phenotype–genotype correlations is limited. To characterize CNM more comprehensively, we retrospectively assessed a national cohort of 48 CNM patients (mean age = 32 ± 24 years, range 0–80, 54% males) from the Netherlands clinically, histologically, and genetically. All information was extracted from entries in the patient's medical records, between 2000 and 2020. Frequent clinical features in addition to muscle weakness and hypotonia were fatigue and exercise intolerance in more mildly affected cases. Genetic analysis showed variants in four genes (18 DNM2, 14 MTM1, 9 RYR1, and 7 BIN1), including 16 novel variants. In addition to central nuclei, histologic examination revealed a large variability of myopathic features in the different genotypes. The identification and characterization of these patients contribute to trial readiness.

[1]  J. Dowling.  Review for "Clinical, genetic and histological features of Centronuclear Myopathy in the Netherlands" , 2021 .

[2]  B. Byrne,et al.  Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis , 2019, Archives of Disease in Childhood.

[3]  Jay F Rowland,et al.  Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study , 2019, The Lancet.

[4]  J. Dowling,et al.  Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease , 2018, Neurotherapeutics.

[5]  J. García-García,et al.  Non-compaction cardiomyopathy and early respiratory failure in an adult symptomatic female carrier of centronuclear myopathy caused by a MTM1 mutation , 2018, Neuromuscular Disorders.

[6]  L. Servais,et al.  An integrated modelling methodology for estimating the prevalence of centronuclear myopathy , 2018, Neuromuscular Disorders.

[7]  Francesco Muntoni,et al.  Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction , 2018, Nature Reviews Neurology.

[8]  L. Mesrob,et al.  Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients , 2017, Neuromuscular Disorders.

[9]  J. Dowling,et al.  A natural history study of X-linked myotubular myopathy , 2017, Neurology.

[10]  A. Laquérriere,et al.  Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues , 2017, Acta Neuropathologica.

[11]  N. Voermans,et al.  Congenital myopathies: not only a paediatric topic. , 2016, Current opinion in neurology.

[12]  E. Bertini,et al.  Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers , 2016, Neuromuscular Disorders.

[13]  A. Janvier,et al.  Dutch neonatologists have adopted a more interventionist approach to neonatal care , 2015, Acta paediatrica.

[14]  B. Onwuteaka-Philipsen,et al.  End-of-life decisions for children under 1 year of age in the Netherlands: decreased frequency of administration of drugs to deliberately hasten death , 2015, Journal of Medical Ethics.

[15]  J. Vissing,et al.  Frequency and Phenotype of Myotubular Myopathy Amongst Danish Patients with Congenital Myopathy Older than 5 Years , 2015, Journal of neuromuscular diseases.

[16]  E. Bertini,et al.  Centronuclear myopathies: genotype–phenotype correlation and frequency of defined genetic forms in an Italian cohort , 2015, Journal of Neurology.

[17]  E. Zanoteli,et al.  DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy , 2015, Genetics and molecular biology.

[18]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[19]  C. Bönnemann,et al.  The neuromuscular differential diagnosis of joint hypermobility , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.

[20]  E. Malfatti,et al.  Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations. , 2014, Brain : a journal of neurology.

[21]  M. Gautel,et al.  Pathogenic Mechanisms in Centronuclear Myopathies , 2014, Front. Aging Neurosci..

[22]  J. Laporte,et al.  Amphiphysin 2 (BIN1) in physiology and diseases , 2014, Journal of Molecular Medicine.

[23]  E. McNally,et al.  Dynamin 2 the rescue for centronuclear myopathy. , 2014, The Journal of clinical investigation.

[24]  M. Tarnopolsky,et al.  Genotype-phenotype correlations in recessive RYR1-related myopathies , 2013, Orphanet Journal of Rare Diseases.

[25]  E. Bertini,et al.  Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort , 2013, Neuromuscular Disorders.

[26]  J. Dowling,et al.  Congenital Myopathies: An Update , 2012, Current Neurology and Neuroscience Reports.

[27]  K. North,et al.  Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy , 2011, PloS one.

[28]  A. Dietz,et al.  Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations , 2011, Journal of Neurology.

[29]  Jocelyn Laporte,et al.  Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation , 2010, Orphanet journal of rare diseases.

[30]  Straub,et al.  RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.

[31]  F. Muntoni,et al.  Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation , 2010, Neuromuscular Disorders.

[32]  T. Sejersen,et al.  Severe phenotype of a patient with autosomal recessive centronuclear myopathy due to a BIN1 mutation. , 2009, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[33]  G. Bassez,et al.  Type 2 Myotonic Dystrophy Can Be Predicted by the Combination of Type 2 Muscle Fiber Central Nucleation and Scattered Atrophy , 2008, Journal of neuropathology and experimental neurology.

[34]  N. Romero,et al.  Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset , 2007, Annals of neurology.

[35]  C. Wallgren‐Pettersson,et al.  Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy , 2007, Nature Genetics.

[36]  N. Romero,et al.  Clinical and histologic findings in autosomal centronuclear myopathy , 2004, Neurology.

[37]  H. Goebel,et al.  Muscle pathology in 57 patients with myotonic dystrophy type 2 , 2004, Muscle & nerve.

[38]  E. Haan,et al.  X‐linked myotubular myopathy in a family with three adult survivors , 2003, Clinical genetics.

[39]  J. Lexell,et al.  Human aging, muscle mass, and fiber type composition. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  M. Fardeau,et al.  Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X inactivation assigns the MTM1 gene to a 600-kb region. , 1995, American journal of human genetics.

[41]  J. Bethlem,et al.  Familial “myotubular” myopathy , 1969, Neurology.

[42]  C. Saris,et al.  Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service. , 2019, Journal of neuromuscular diseases.

[43]  N. Voermans,et al.  Dominant Centronuclear Myopathy with Early Childhood Onset due to a Novel Mutation in BIN1. , 2017, Journal of neuromuscular diseases.

[44]  A. Beggs,et al.  Mutations in dynamin 2 cause dominant centronuclear myopathy. , 2005, Nature genetics.